Should I Buy NVNO? NVNO 2026 Analysis

Should You Buy enVVeno Medical Corp (NVNO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

10.010

1 Day change

-2.44%

52 Week Range

196.700

Analysis Updated At

2026/01/26

enVVeno Medical Corp (NVNO) is not a strong buy at this time for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading or sentiment signals to support immediate investment.

Technical Analysis

The MACD is positive and expanding, indicating some bullish momentum. However, RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 13.08 and 13.954, while support levels are at 10.254 and 9.38. The stock is trading near its pivot point of 11.667, suggesting limited upward movement in the short term.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options data shows a very low put-call ratio, indicating minimal bearish sentiment. However, the overall volume and open interest are low, suggesting limited market activity or interest in the stock.

Technical Summary

Sell

Buy

Positive Catalysts

NULL identified. There is no recent news, and no significant insider or hedge fund activity. Technical indicators show limited bullish momentum.

Neutral/Negative Catalysts

Weak financial performance in Q3 2025, with a YoY net income drop of -19.55% and EPS decline of -34.29%. No recent congress trading data or influential figure activity. Analyst sentiment and price target trends are unavailable.

Financial Performance

In Q3 2025, the company reported zero revenue growth (0% YoY), a net income loss of -$4,539,000 (-19.55% YoY), and a significant EPS decline of -34.29%. Gross margin remains at 0%, indicating no profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available on analyst ratings or price target changes, making it difficult to gauge Wall Street sentiment.

Analyst Rating

Wall Street analysts forecast NVNO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVNO is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy